FDA Investigator Jie He
Jie He has inspections in 6 countries as of 19 Sep 2023. Jie He has collaborated with a combined 1634 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
United States of America,
France,
Austria,
Taiwan,
Sweden
Co-Investigator(s):
Adam R Cooke,
Alan L Truong,
Alice C Silva,
Andrew Chang,
Andrey Sarafanov, PhD,
Ann Marie Montemurro,
Anthony F Lorenzo,
Arie C Menachem,
Binh T Nguyen,
Bonita S Chester,
Burnell M Henry,
Calvin B Koerner,
Carl A Perez,
CDR Thomas R Berry, PPh,
Charles Yuanchia Kuo, PhD,
Cynthia Jim, CSO,
Daniel L Zheng,
Devaughn Edwards,
Dino Feigelstock (DF), PhD,
Donald C Obenhuber, PhD,
Dr. Gang Wang, PhD,
Dr. Ralph M Bernstein, PhD,
Eileen A Liu,
Erik W Koester,
Gilbert T Salud,
Hai Lien T Phung,
Ibad U Khan,
Jacqueline Mdiaz Albertini,
James R Evans,
Janet L Bowen,
Jason F Chancey,
Jennifer L Reed,
Joan A Loreng,
John P Mistler,
Jonathan G Matrisciano,
Jose Acruz Gonzalez,
Joseph F Owens,
Joseph Kutze, PhD,
Joshua P Wireman,
Justin A Boyd,
Katherine D Adams,
Kirsten L Vadheim, PhD,
Kristen D Evans,
Kristin M Abaonza,
Laura I Salazar, PhD,
LCDR Debra Emerson,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Lois K Gross,
Lu Deng,
Marion Michaelis,
Mary P Padgett,
Michael C Kennedy, PhD,
Michael J Vardon,
Michael R Klapal,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Mindy M Chou,
Nancy Kirschbaum, PhD,
Obinna R Echeozo,
Olga Simakova,
Omotunde O Osunsanmi,
Pankaj H Amin,
Parul M Patel,
Paula A Trost,
Prabhu P Raju,
Priscilla M Pastrana,
Qiao Y Bobo,
Rajiv R Srivastava,
Randa Melhem, PhD,
Rebecca K Olin,
Rebecca Rodriguez,
Robert W Jennings,
Roger F Zabinski,
Scott T Ballard,
Seneca D Toms,
Sidney B Priesmeyer,
Siliva Wanis, PharmD,
Sony Mathews,
Susan M Jackson,
Tamara M Casselman,
Thuy T Nguyen, LCDR,
Viviana Matta,
Wayne E Seifert,
Wendy G Tan, PhD,
Yonggang Wang, PhD,
Yuan Chia Kuo,
Ze Peng,
Zhao Wang, PhD,
Zhihao Qiu (Peter), PhD
Jie He's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2012 | FDA 483 | Octapharma AB - Form 483, 2012-07-30 |
April, 2016 | FDA 483 | ADIMMUNE CORPORATION - Form 483, 2016-04-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more